Roche Elecsys IGRA TB Blood Test Gains CE Mark for Latent TB Detection
Roche announced that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing…
Roche gets CE Mark for TB blood test
Roche (OTCQX:RHHBY) received CE Mark for its Elecsys IGRA TB blood test, enabling automated identification of tuberculosis infection…
Roche Receives CE Mark for Multiple Sclerosis Blood Test
Roche has received the CE mark for its Elecsys Neurofilament Light Chain (NfL) for the detection of neuroinflammation…
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in-vitro diagnostic (IVD)…
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…